BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17112568)

  • 1. The treatment of early stage cervical cancer: an assessment of pre-operative factors.
    Buekers TE; Kao MS; Phillips NJ; Xynos FP
    Gynecol Oncol; 2007 Mar; 104(3):665-9. PubMed ID: 17112568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
    Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG
    J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A clinical retrospective review of stage IB1 and IB2 cervical cancer].
    Shao S; Sun L; Sun L
    Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):66-8. PubMed ID: 11776803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy.
    Yessaian A; Magistris A; Burger RA; Monk BJ
    Gynecol Oncol; 2004 Jul; 94(1):61-6. PubMed ID: 15262120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer.
    Lowe MP; Chamberlain DH; Kamelle SA; Johnson PR; Tillmanns TD
    Gynecol Oncol; 2009 May; 113(2):191-4. PubMed ID: 19249082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
    dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
    Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Wertheim-operation: 5-year survival of 501 consecutive patients with cervical cancer].
    Papp Z; CsapĆ³ Z; Mayer A; Hupuczi P
    Orv Hetil; 2006 Mar; 147(12):537-45. PubMed ID: 16696377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
    Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A validation study of new risk grouping criteria for postoperative treatment in stage IB cervical cancers without high-risk factors: rethinking the Gynecologic Oncology Group criteria.
    Chang SJ; Kim WY; Yoo SC; Yoon JH; Chun M; Chang KH; Ryu HS
    Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):91-6. PubMed ID: 19695765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-assessment of stage I uterine cervical carcinoma according to revised JSGO (1997) staging.
    Morimura Y; Nishiyama H; Hashimoto T; Fujimori K; Yamada H; Yanagida K; Sato A
    Fukushima J Med Sci; 1999 Dec; 45(2):109-16. PubMed ID: 11039607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
    Chen MF; Tseng CJ; Tseng CC; Yu CY; Wu CT; Chen WC
    Cancer J; 2008; 14(3):200-6. PubMed ID: 18536561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of postoperative complications of radical hysterectomy for 219 cervical cancer patients].
    Wu K; Zhang WH; Zhang R; Li H; Bai P; Li XG
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):316-9. PubMed ID: 16875638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma.
    Diaz JP; Sonoda Y; Leitao MM; Zivanovic O; Brown CL; Chi DS; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2008 Nov; 111(2):255-60. PubMed ID: 18755500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of tailored adjuvant postoperative chemoradiotherapy in IB FIGO stage cervical cancer.
    Fabrini MG; Gadducci A; Perrone F; Cosio S; Laliscia C; Pasqualetti F; Grespi S; Cionini L
    Anticancer Res; 2009 Oct; 29(10):4205-10. PubMed ID: 19846974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of 16 patients with early cervical cancer treated by laparoscopic vaginal radical trachelectomy].
    Shen K; Lang JH; Yang JX; Chen YL; Xiang Y; Hua KQ; Huang HF; Pan LY; Wu M; Feng YJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):222-5. PubMed ID: 16759453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk grouping in stage IB squamous cell cervical carcinoma.
    Van de Putte G; Lie AK; Vach W; Baekelandt M; Kristensen GB
    Gynecol Oncol; 2005 Oct; 99(1):106-12. PubMed ID: 16137752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical vaginal trachelectomy vs. radical hysterectomy for small early stage cervical cancer: a matched case-control study.
    Beiner ME; Hauspy J; Rosen B; Murphy J; Laframboise S; Nofech-Mozes S; Ismiil N; Rasty G; Khalifa MA; Covens A
    Gynecol Oncol; 2008 Aug; 110(2):168-71. PubMed ID: 18539313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors.
    Mabuchi S; Morishige K; Isohashi F; Yoshioka Y; Takeda T; Yamamoto T; Yoshino K; Enomoto T; Inoue T; Kimura T
    Gynecol Oncol; 2009 Dec; 115(3):482-7. PubMed ID: 19783286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.